Komodo Health announced on August 7, 2024, that it was included in the 2024 Forbes Cloud 100, the annual ranking of the top 100 private cloud companies. The company said this was its fourth Cloud 100 recognition. The announcement is a historical 2024 event, not evidence of Komodo’s latest ranking in 2026.
What Komodo Health announced
In a company announcement dated August 7, 2024, Komodo Health said it had been named to the 2024 Forbes Cloud 100. Komodo described the appearance as its fourth Cloud 100 recognition.
The release does not disclose Komodo’s numerical position among the 100 companies. It is therefore accurate to say that Komodo was included or named to the list, not that it finished at a particular rank.
What the Forbes Cloud 100 measures
Forbes describes the Cloud 100 as an annual ranking of leading private cloud companies. The 2024 edition was identified as the ninth annual list and was produced with Bessemer Venture Partners and Salesforce Ventures.
Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →#1 Best Overall
According to Komodo’s release, submissions were assessed across four categories:
| Evaluation factor | Stated weighting | What readers should infer |
|---|---|---|
| Market leadership | 35% | Relative position and perceived leadership in a company’s market; CEOs of public cloud companies assisted with judging. |
| Estimated valuation | 30% | Investor or market perception of company value, not a disclosed Komodo valuation. |
| Operating metrics | 20% | Business-performance information considered by the ranking; Komodo’s individual figures were not published. |
| People and culture | 15% | A component of the methodology, not an independent workplace audit. |
The release also attributed an aggregate 2024 Cloud 100 list value of $820 billion to Bessemer Venture Partners, more than $150 billion higher than the prior year. Those figures describe the list as a whole and do not reveal Komodo’s revenue, growth, valuation or profitability.
Why Komodo fits a private-cloud-company ranking
Komodo presents itself as a healthcare technology and analytics company. Its stated platform combines patient-encounter data, artificial intelligence, algorithms and cloud software to generate real-world healthcare insights.
The company says its intended customers include:
- Life-sciences companies
- Payers
- Providers
- Healthcare and digital-health developers
Komodo says its products are designed to support decisions such as identifying gaps in care, analyzing disease burden and studying patient journeys for value-based healthcare. These are company descriptions and positioning claims, rather than independent findings established by the Cloud 100 announcement.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
What the fourth recognition means
Komodo said the 2024 listing marked its fourth Cloud 100 honor. That repeated appearance indicates sustained visibility in a prominent private-cloud ranking. It also shows that healthcare data and analytics can be evaluated alongside broader enterprise-cloud businesses.
Komodo President Web Sun said the recognition reflected the company’s commitment to healthcare analytics and real-world insights. His comments explain Komodo’s strategic narrative, but they are promotional statements rather than an independent assessment of product performance.
What this recognition does—and does not—prove
What it indicates
- Forbes, Bessemer Venture Partners and Salesforce Ventures considered Komodo competitive under the list’s stated criteria.
- The company has achieved repeated visibility in the private-cloud market.
- Investors and industry observers regarded healthcare analytics as a significant cloud-software category in 2024.
What remains unestablished
- Komodo’s exact list position or score.
- Its valuation, revenue, growth rate, margins, customer count or profitability.
- That Komodo has the best, most complete or least biased healthcare data.
- That its platform improves clinical outcomes or delivers a particular customer return on investment.
- That its products are appropriate for every healthcare organization.
- That the award is a clinical-quality certification, regulatory approval or security audit.
The methodology’s use of estimated valuation is especially important context: a high private-company valuation can signal investor expectations, but it is not the same as proven profitability, data accuracy or customer value.
Questions a buyer should ask before evaluating Komodo
A Cloud 100 appearance can establish market recognition, but a healthcare-data purchase requires its own diligence. Prospective customers should request clear answers to the following:
Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchPC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11- Data coverage: Which claims, clinical, pharmacy or other sources are included, and which populations and geographies do they represent?
- Completeness and refresh: How often is data updated, and what known gaps, coding variation or reporting delays affect it?
- Linkage: How are records connected across sources, and how is linkage quality measured?
- Validation: Can the vendor provide independent validation, error measures and examples relevant to the intended use case?
- Privacy and security: What safeguards, contractual restrictions and permitted-use rules apply to the data?
- Use-case boundaries: Is the product intended for market analysis, real-world evidence, care-gap work or another purpose? The announcement does not establish autonomous diagnosis or treatment capability.
- Implementation: What integrations, technical resources, training and ongoing governance are required?
- Commercial terms: Is pricing based on users, modules, data access, use cases or enterprise licensing?
These questions also apply when comparing vendors such as IQVIA, Clarivate, Definitive Healthcare, Datavant and Truveta. Their suitability depends on data sources, linkage, analytics depth, permitted uses and implementation requirements—not on a single awards list.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.How to read the announcement in 2026
The announcement should be dated to 2024 when cited. It supports a conclusion about Komodo’s recognition at that time, not a claim that the company currently holds the newest Forbes Cloud 100 position. No current ranking, updated score or later recognition is established by this announcement.
For investors, employees and industry observers, the practical takeaway is limited but meaningful: Komodo had enough perceived market leadership, private-company value, operating strength and organizational appeal to be included in a major cloud-company ranking. Anyone making a financing, employment or vendor decision should pair that signal with current financial information, security documentation, product demonstrations, data specifications and independent customer evidence.
Bottom line
Komodo Health’s August 7, 2024 announcement confirms inclusion in the 2024 Forbes Cloud 100 and identifies it as the company’s fourth recognition. That is a credible indicator of private-cloud market visibility. It is not proof of a specific rank, financial performance, healthcare-data superiority or clinical impact, so those questions require separate evidence.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
